Palliative Care — Complementary Therapy in Home Palliative Care Patients and Their Caregivers
Citation(s)
Bradt J, Dileo C, Magill L, Teague A Music interventions for improving psychological and physical outcomes in cancer patients. Cochrane Database Syst Rev. 2016 Aug 15;(8):CD006911. doi: 10.1002/14651858.CD006911.pub3. Review.
Gallagher LM, Lagman R, Rybicki L Outcomes of Music Therapy Interventions on Symptom Management in Palliative Medicine Patients. Am J Hosp Palliat Care. 2018 Feb;35(2):250-257. doi: 10.1177/1049909117696723. Epub 2017 Mar 9.
Keenan A, Keithley JK Integrative Review: Effects of Music on Cancer Pain in Adults. Oncol Nurs Forum. 2015 Nov;42(6):E368-75. doi: 10.1188/15.ONF.E368-E375. Review.
Kordovan S, Preissler P, Kamphausen A, Bokemeyer C, Oechsle K Prospective Study on Music Therapy in Terminally Ill Cancer Patients during Specialized Inpatient Palliative Care. J Palliat Med. 2016 Apr;19(4):394-9. doi: 10.1089/jpm.2015.0384. Epub 2016 Fe
McConnell T, Scott D, Porter S Music therapy for end-of-life care: An updated systematic review. Palliat Med. 2016 Oct;30(9):877-83. doi: 10.1177/0269216316635387. Epub 2016 Mar 4. Review.
Qi He Mabel L, Drury VB, Hong PW The experience and expectations of terminally ill patients receiving music therapy in the palliative setting: a systematic review. JBI Libr Syst Rev. 2010;8(27):1088-1111.
Williams AL, McCorkle R Cancer family caregivers during the palliative, hospice, and bereavement phases: a review of the descriptive psychosocial literature. Palliat Support Care. 2011 Sep;9(3):315-25. doi: 10.1017/S1478951511000265. Review.
Complementary Therapy in Home Palliative Care Patients and Their Caregivers. A Clinical Trial
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
